Limmatech Biologics Ag
Clinical trials sponsored by Limmatech Biologics Ag, explained in plain language.
-
New vaccine could stop recurring yeast infections in women
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called Candi5V in women who get frequent yeast infections (at least 3 per year). The goal is to see if the vaccine is safe and helps the body build immunity against the fungus that causes these infections. About 251 women will receive either the vac…
Phase: PHASE1, PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 12:10 UTC
-
New shigella vaccine shows promise in early trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called Shigella4V2 to see if it can protect healthy adults from shigellosis, a diarrheal disease caused by Shigella bacteria. About 120 volunteers aged 18-50 will receive either the vaccine or a placebo and then be exposed to the bacteria in a contr…
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 12:02 UTC